Have you registered to the new Evaluate monthly newsletter yet? Don't miss out on our most-read content delivered straight to your inbox. Sign up to receive the Evaluate Discovery newsletter now! ???https://ow.ly/N0AF50TiRnt
Evaluate Ltd
信息服务
Evaluate provides trusted commercial intelligence and predictive analytics to the pharmaceutical industry
关于我们
Evaluate provides trusted commercial intelligence and forecasting models for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global biopharma market to drive better decisions. Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action. Evaluate Pharma - the trusted global view of the pharmaceutical market’s past, present and future performance with consensus forecasts to 2030, company financials, pipelines, deals and more. Evaluate Omnium - provides a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, delivering game-changing insight into pharma asset potential. Forecasting Solutions - Ensure precise and efficient forecasting at every stage of your product lifecycle. Our comprehensive suite of forecasting solutions tailored to the pharmaceutical industry, including software, cloud-based platforms, custom-built models, advanced analytics and data. Our forecasting solutions support forecasters through new product planning, launch, and commercialisation. CDMO Intelligence - Access CDMO screening, molecular landscape insights, detailed manufacturing capabilities, and accurate volume forecasts. You’ll have a wealth of data and industry insights at your fingertips, backed by gold standard financial forecast methodologies. Consulting and Analytics - Evaluate’s consulting and analytics team is here to help clients address unique scientific, clinical and commercial challenges. We answer key asset, portfolio strategy, and corporate strategy-related business questions, powered by the combined resources of Norstella, one of the world’s largest pharma intelligence solutions providers. Evaluate’s combination of leading data sources, deep pharma expertise, robust methodologies, data science and real-world data will ensure your teams make the right decisions to drive your growth.
- 网站
-
https://www.evaluate.com
Evaluate Ltd的外部链接
- 所属行业
- 信息服务
- 规模
- 51-200 人
- 总部
- London
- 类型
- 私人持股
- 创立
- 1996
- 领域
- pharma business analysis、pharma licensing deals、pharma consensus forecasts、biotech business analysis、pharma competitive intelligence、medtech consensus forecasts、pharma business developement、pharma R&D analysis、pharma data、pharma forecasting models、Real World Data、Pharma portfolio strategy、Pharma Consulting和BD&L consulting
地点
Evaluate Ltd员工
动态
-
?? It's Meet the Team time! ?? https://ow.ly/h2Ll50UgLeU We'd love you to meet ????Penny Wills, Senior Director of Implementation in our forecasting team. Check it out to learn why Penny's an advocate for connecting pharma companies with their patients - and why she'd be a useful addition if you've got some heavy boxes to shift.??
-
-
https://ow.ly/HL7J50UfWg2 It's over 10 years since the first “hub and spoke” biotechs launched. We've investigated whether the portfolio business model has been validated. Have the likes of Roivant delivered the innovation and commercial success that investors demand? And which players are the ones to watch in future?
-
https://ow.ly/n0Y150UeSKC What are the top pitfalls in pharma competitive intelligence programmes? Catch our on-demand webinar with our CI expert, Kelly Chamberlain, Ph.D. to understand top challenges in CI - and how to overcome them.
-
A recent survey by Norstella found that over half of all companies are now routinely harnessing AI in drug development programs. In this article for Clinical Leader, Daniel Chancellor considers the potential impact - and roadblocks - for the transformative power of AI in pharma. https://ow.ly/ef5950UcMuM
-
Evaluate Ltd转发了
Will you be joining us today for our webinar covering what’s required to achieve launch excellence? https://ow.ly/FwWt50UaUmg Click here to register and we’ll see you at 3pm GMT (10am EDT) https://ow.ly/FwWt50UaUmg
-
-
https://ow.ly/R6aC50Ub4x3 If you missed our webinar where we discussed highlights from BIO-Europe, why not check the blog with a few of the things we learned in the session? Our experts covered dealmaking trends and opportunities in China - and were challenged to predict the mood at JP Morgan in January.
-
-
There's a lot of buzz about CDMOs but are they here to stay or are they just the latest trend in a market always looking to evolve? We ran a roundtable at the recent CPHI event to ask that very question. What was the verdict? https://ow.ly/gC2E50U97a7
-
Are you involved in pharma product launch? Don't miss our upcoming webinar From Trials to Take Off: The Road to Launch Excellence. https://ow.ly/Ytnu50U7LY0 In the session you will learn best practices for adapting forecasts, planning for market shifts, and maximising ROI during launch.
-
-
Final boarding call for today's webinar! https://ow.ly/jOkB50U6W6i Our expert panel will be discussing the big trends in the pharma market as we approach year end and taking questions from the audience. Come and join us!
-